Denmark is heading for its worst year of job losses since the Covid pandemic, as sweeping cuts at pharmaceutical giant Novo ...

Novo Nordisk (NVO) announced 5,000 job cuts in Denmark last September, putting the Nordic nation to record its worst year for ...

Novo Nordisk stock has performed well this year, but you may be surprised at its return over the past three years. The growing popularity of its Wegovy and Ozempic products has generated plenty of ...

Novo Nordisk A/S NVO announced that it has submitted a label expansion application to the European Medicines Agency (EMA) for the marketing authorization of Ozempic to include a new dose of 2.0 mg. We ...

Novo Nordisk A/S (NVO) announced that the FDA has approved an updated label for Saxenda (liraglutide) injection 3 mg. The Saxenda Injection is now approved for the treatment of obesity in adolescents ...

With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in the realm of rare disease. Over the weekend, Novo unveiled data from the ...